HUH7 cells treated with gradually increasing concentrations of sorafenib for 6 months
收藏NIAID Data Ecosystem2026-05-10 收录
官方服务：
资源简介：
To explore the mechanism of sorafenib resistance.
探究索拉非尼（sorafenib）耐药机制。
应用场景：
创建时间：
2025-12-31
相关数据集
Endogenous protein S100A14 stabilizes glutaminase to render hepatocellular carcinoma resistant to sorafenib
Many cases of advanced hepatocellular carcinoma (HCC) are resistant to the widely used drug sorafenib, which worsens prognosis. While many studies have explored how acquired resistance emerges during
NIAID Data Ecosystem100
NEK7 induced phosphorylation of EGFR on serine 1070 drive the acquired lenvatinib resistance in hepatocellular carcinoma
NEK7 induced phosphorylation of EGFR on serine 1070 drive the acquired lenvatinib resistance in hepatocellular carcinoma
integrated proteome resources60
Metabolic state determines drug response in liver cancer
Drug resistance is one of the most challenging problems in liver cancer research. The hepatocellular carcinoma cell line HLE is highly dependent on exogenous glutamine for proliferation. In this cell
NIAID Data Ecosystem30
Homo sapiens Raw sequence reads. Homo sapiens
We established the sorafenib-resistant hepatocellular carcinoma cell sublines (HUH7-S and SMMC7721-S), and whole-transcriptome sequencing was performed on drug-resistant cells and parental cells. DEln
NIAID Data Ecosystem100
Cancer-associated Fibroblast-derived SPP1 is a Potential Target for Overcoming Sorafenib and Lenvatinib Resistance in Hepatocellular Carcinoma. Cancer-associated Fibroblast-derived SPP1 is a Potential Target for Overcoming Sorafenib and Lenvatinib Resistance in Hepatocellular Carcinoma
Abstract: Cancer-associated fibroblasts (CAFs) play an important role in the induction of chemo-resistance. The objectives of this study were to clarify the mechanism underlying CAF-mediated sorafenib
NIAID Data Ecosystem60
